Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
C3.ai
AI
$1.58B
| $7.29M | ﹤0.01% |
540,774
+207,864
| +62% | +$3.32M |
|
1927
Americold
COLD
$4.32B
| $7.29M | ﹤0.01% |
566,752
+457,279
| +418% | +$5.61M |
|
|
CVSA
1928
Covista Inc
CVSA
$4.49B
| $7.29M | ﹤0.01% |
70,430
+3,982
| +6% | +$456K |
|
1929
NovaGold Resources
NG
$3.4B
| $7.28M | ﹤0.01% |
781,488
-65,660
| -8% | -$609K |
|
1930
Full Truck Alliance
YMM
$9.2B
| $7.28M | ﹤0.01% |
678,130
+104,519
| +18% | +$1.25M |
|
1931
Dianthus Therapeutics
DNTH
$6.13B
| $7.27M | ﹤0.01% |
176,300
-28,069
| -14% | -$1.09M |
|
1932
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.44B
| $7.26M | ﹤0.01% |
230,871
-32,219
| -12% | -$1.01M |
|
1933
Garrett Motion
GTX
$5.35B
| $7.22M | ﹤0.01% |
414,349
+48,266
| +13% | +$768K |
|
1934
Warrior Met Coal
HCC
$4.98B
| $7.22M | ﹤0.01% |
81,874
+5,996
| +8% | +$451K |
|
1935
Brookfield Renewable
BEPC
$6.66B
| $7.21M | ﹤0.01% |
188,120
+149,706
| +390% | +$6.02M |
|
|
SGI
1936
CALL
Somnigroup International
SGI
$14B
| $7.2M | ﹤0.01% |
80,700
| – | – |
|
1937
Advanced Drainage Systems
WMS
$11.3B
| $7.2M | ﹤0.01% |
49,732
-18,464
| -27% | -$2.67M |
|
1938
MDU Resources
MDU
$4.27B
| $7.17M | ﹤0.01% |
367,301
+199,527
| +119% | +$3.93M |
|
|
NNAVW
1939
DELISTED
NextNav Inc Warrant
NNAVW
| $7.17M | ﹤0.01% |
1,002,458
-972,567
| -49% | -$5.43M |
|
1940
CALL
Prologis
PLD
$134B
| $7.1M | ﹤0.01% |
55,600
| – | – |
|
|
HUT
1941
Hut 8
HUT
$10.2B
| $7.09M | ﹤0.01% |
154,407
-6,349
| -4% | -$280K |
|
1942
Kinsale Capital Group
KNSL
$8.59B
| $7.08M | ﹤0.01% |
18,106
-3,947
| -18% | -$1.61M |
|
1943
ScottsMiracle-Gro
SMG
$3.59B
| $7.08M | ﹤0.01% |
121,347
-33,108
| -21% | -$1.86M |
|
1944
Universal Technical Institute
UTI
$1.42B
| $7.07M | ﹤0.01% |
270,709
-168,513
| -38% | -$4.77M |
|
1945
PUT
Costco
COST
$427B
| $7.07M | ﹤0.01% |
8,200
-17,100
| -68% | -$15.5M |
|
1946
Travel + Leisure Co
TNL
$4.58B
| $7.07M | ﹤0.01% |
100,227
-33,649
| -25% | -$2.2M |
|
1947
Avista
AVA
$3.24B
| $7.06M | ﹤0.01% |
183,224
+34,989
| +24% | +$1.37M |
|
1948
PUT
3M
MMM
$94.2B
| $7.04M | ﹤0.01% |
44,000
-307,800
| -87% | -$50.3M |
|
1949
Life Time Group Holdings
LTH
$9.9B
| $7.04M | ﹤0.01% |
264,726
+43,548
| +20% | +$1.13M |
|
|
XYZ
1950
PUT
Block Inc
XYZ
$49.9B
| $7.04M | ﹤0.01% |
108,100
-30,900
| -22% | -$2.13M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.